These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9833400)

  • 1. Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesionek-Kupnicka D; Buczyński J; Kordek R; Sobów T; Kłoszewska I; Papierz W; Liberski PP
    Folia Neuropathol; 1997; 35(4):233-5. PubMed ID: 9833400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis?
    Ferrer I
    Acta Neuropathol; 1999 Jan; 97(1):5-12. PubMed ID: 9930889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal loss and apoptosis in experimental Creutzfeldt-Jakob disease in mice.
    Jesionek-Kupnicka D; Buczyński J; Kordek R; Liberski PP
    Folia Neuropathol; 1999; 37(4):283-6. PubMed ID: 10705654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease with Alzheimer-type A beta-reactive amyloid plaques.
    Barcikowska M; Kwiecinski H; Liberski PP; Kowalski J; Brown P; Gajdusek DC
    Histopathology; 1995 May; 26(5):445-50. PubMed ID: 7657313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
    Ferrer I
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer's Disease.
    Zafar S; Younas N; Correia S; Shafiq M; Tahir W; Schmitz M; Ferrer I; Andréoletti O; Zerr I
    Mol Neurobiol; 2017 Jan; 54(1):697-709. PubMed ID: 26768426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
    Armstrong RA; Lantos PL; Cairns NJ
    Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Leenheir E; Lübke U; Martin JJ; Cras P
    Acta Neuropathol; 2004 Sep; 108(3):194-200. PubMed ID: 15221335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
    Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
    Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings.
    Van Everbroeck B; Pals P; Dziedzic T; Dom R; Godfraind C; Sciot R; Brucher JM; Martin JJ; Cras P
    Acta Neuropathol; 2000 Apr; 99(4):358-64. PubMed ID: 10787033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
    Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
    Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.
    Hainfellner JA; Wanschitz J; Jellinger K; Liberski PP; Gullotta F; Budka H
    Acta Neuropathol; 1998 Aug; 96(2):116-22. PubMed ID: 9705125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
    Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
    Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent stress response of Purkinje cells in Creutzfeldt-Jakob disease.
    Kovács GG; Kurucz I; Budka H; Adori C; Müller F; Acs P; Klöppel S; Schätzl HM; Mayer RJ; László L
    Neurobiol Dis; 2001 Oct; 8(5):881-9. PubMed ID: 11592855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Dewulf E; Pals P; Lübke U; Martin JJ; Cras P
    Neurobiol Aging; 2002; 23(1):59-64. PubMed ID: 11755020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
    Shin RW; Ogomori K; Kitamoto T; Tateishi J
    Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?
    Kovacs GG
    Prion; 2016 Sep; 10(5):369-376. PubMed ID: 27649940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.